2022年4月11日 · A carcinoembryonic antigen (CEA) test measures your levels of a specific protein called CEA. Healthcare providers use the test to guide or monitor cancer treatment.

2022年10月29日 · Carcinoembryonic antigen (CEA) is a tumor marker found in the blood or in other bodily fluids that can be used to monitor treatment for certain cancers. This article explains what the CEA test is, when it can be helpful in cancer treatment, and how to interpret its results.

2022年8月17日 · Doctors don’t always see obvious signs of cancer growth after a diagnosis. They need to hunt for clues. One way they can do that is with a carcinoembryonic antigen test. It measures a protein...

2021年11月15日 · A CEA test measures the level of carcinoembryonic antigen (CEA) in the blood or other body fluid. As a type of tumor marker, CEA is an indicator of whether cancer is growing and spreading or diminishing with treatment.

Carcinoembryonic antigen (CEA) describes a set of highly-related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth.

Carcinoembryonic antigen (CEA) is used as a tumor marker. An elevated or rising CEA level indicates cancer progression or recurrence. Read on to learn about the meaning of different CEA blood ranges, the CEA test, and how to know what a healthy blood test range is for CEA.

2024年12月11日 · Carcinoembryonic antigen (CEA) is a nonspecific serum biomarker that is elevated in many malignancies, including colorectal cancer, medullary thyroid cancer, breast cancer, and mucinous ovarian cancer.

Learn about the carcinoembryonic antigen (CEA) biomarker and how it is used in the diagnosis, monitoring, and treatment of your colorectal cancer.

A CEA (carcinoembryonic antigen) test measures CEA in a sample of blood or other body fluid. It helps check if treatment for certain cancers is working. Learn more.

Carcinoembryonic antigen is a type of glycoprotein that is typically present in low levels in the blood of healthy adults. It belongs to the immunoglobulin superfamily and is mainly produced during fetal development. In adults, CEA levels usually remain low but can increase in response to certain medical conditions, particularly cancers.